PureCycle Technologies, Inc. (PCT) - 10-Q Summary for Q3 2024
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. PureCycle Technologies, Inc. is a Florida-based corporation commercializing patented purification recycling technology to convert waste polypropylene into ultra-pure recycled (UPR) resin. The company operates its first commercial-scale facility in Ironton, Ohio, and is developing a multi-line facility in Augusta, Georgia. As of the reporting date, the company has not yet achieved meaningful production volumes or significant revenue, focusing instead on customer sampling, qualifications, and resolving mechanical challenges at the Ironton Facility.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|
| Revenue | Immaterial / Not Disclosed | Immaterial / Not Disclosed | Immaterial / Not Disclosed |
| Net Loss | $(90.6) million | $(224.5) million | $(72.7) million |
| Loss Per Share (Diluted) | $(0.54) | $(1.36) | $(0.45) |
| Total Operating Expenses | $31.3 million | $110.2 million | $80.0 million |
| Interest Expense | $14.6 million | $41.7 million | $16.2 million |
| Cash and Cash Equivalents | $83.7 million (as of Sept 30, 2024) | N/A | |
| Restricted Cash | $10.0 million (as of Sept 30, 2024) | N/A | |
| Long-Term Debt (Net) | $255.0 million (as of Sept 30, 2024) | N/A | |
| Related Party Debt | $74.4 million (as of Sept 30, 2024) | N/A | |
| Net Cash Used in Operating Activities | N/A | $(113.0) million | $(61.3) million |
Material Changes vs. Prior Period
- Net Loss Expansion: The net loss for the nine months ended September 30, 2024, increased to $224.5 million from $72.7 million in the prior year period. This was driven primarily by a $54.5 million expense from the change in fair value of warrants and a $21.2 million loss on debt extinguishment.
- Operating Costs: Operating costs increased by 68% year-over-year for the nine-month period ($60.4 million vs. $36.0 million), largely due to $14.0 million in higher depreciation as Ironton Facility assets were placed in service and $11.5 million in increased operational site costs.
- Debt Restructuring: In March 2024, the company purchased 99% of its outstanding Revenue Bonds, resulting in a debt extinguishment loss. Subsequently, the company resold approximately $116.8 million of these bonds to related parties and third parties.
- Financing Activity: In September 2024, the company raised approximately $90 million through a private placement of Series A Preferred Stock, Common Stock, and Series C Warrants. Additionally, the company extended its $200 million revolving credit facility maturity to March 31, 2026.
- Liquidity Position: Unrestricted liquidity decreased from $121.6 million at year-end 2023 to $83.7 million at September 30, 2024, as the company liquidated its available-for-sale debt securities portfolio and utilized cash for bond repurchases and operations.
Guidance, Outlook, Risks, and Contingencies
- Going Concern: Management has disclosed that conditions raise substantial doubt about the company's ability to continue as a going concern for one year from the filing date. However, management believes this doubt is alleviated by plans to re-market bonds, operational enhancements, and recent financing.
- Operational Challenges: The Ironton Facility faces intermittent mechanical challenges, specifically regarding the removal of polyethylene and other solids (CP2), which limits production volumes and product consistency. The company is testing system modifications to address these issues.
- Augusta Facility: Construction of the Augusta Facility is ongoing, with approximately $95.9 million invested to date. The company faces uncertainty regarding project financing and must demonstrate continuous construction progress to retain economic development incentives.
- Legal Proceedings:
- Securities Litigation: A securities class action lawsuit (Consolidated Theodore Lawsuit) was settled for $12 million, funded by D&O insurance, with court approval received in October 2024.
- Derivative Litigation: A derivative settlement was reached for $3 million (funded by D&O insurance) covering multiple shareholder derivative actions, pending court approval.
- Southgate Lawsuit: A pending securities lawsuit regarding operational disclosures remains active, with a motion to dismiss hearing scheduled for November 2024.
- Arbitration: An arbitration with Denham-Blythe Company regarding construction disputes at the Ironton Facility is ongoing, with the contractor seeking approximately $17.0 million.
- Regulatory: The company received an expanded FDA Letter of No Objection in June 2024, allowing UPR resin made from food-grade post-consumer recycled material to be used in contact with all food types.
Key Facts for Investor Verification
- Production Status: Verify the timeline for resolving CP2 removal issues at the Ironton Facility and the expected date for achieving meaningful, continuous on-spec production volumes.
- Liquidity Runway: Confirm the sufficiency of the $83.7 million unrestricted cash balance against the stated $60.6 million in upcoming interest and principal payments and ongoing operational burn rates.
- Bond Re-marketing: Assess the progress and terms of re-marketing the $117.6 million of outstanding Revenue Bonds held by the company to generate additional liquidity.
- Augusta Financing: Monitor the status of securing project financing for the Augusta Facility, which is critical for meeting the December 31, 2026, construction deadline and retaining tax incentives.
- Legal Exposure: Track the outcome of the Southgate securities lawsuit and the Denham-Blythe arbitration, as these could result in material cash outflows or operational disruptions.